104 Drug Survival of Second Biologic Dmard Therapy in Patients with Rheumatoid Arthritis: Comparison of a Second Anti-Tumour Necrosis Factor with a Second Non-Anti-Tumour Necrosis Factor after Discontinuation of a First Anti-Tumour Necrosis Factor
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.